Eliem Therapeutics Net Profit Margin 2021-2024 | CLYM
Eliem Therapeutics net profit margin from 2021 to 2024. Net profit margin can be defined as net Income as a portion of total sales revenue.
Eliem Therapeutics Net Profit Margin Historical Data |
Date |
TTM Revenue |
TTM Net Income |
Net Margin |
Sector |
Industry |
Market Cap |
Revenue |
Medical |
MED-DRUGS |
$0.342B |
$0.000B |
Eliem Therapeutics Inc. is a clinical-stage biotechnology company. It focused on developing novel therapies for neuronal excitability disorders to address unmet needs in chronic pain, psychiatry, epilepsy and other disorders of the peripheral and central nervous systems. Eliem Therapeutics Inc. is based in SEATTLE, United Kingdom.
|